Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 20

1.

Mobilizing EPCs: It is not just an acute issue.

Taylor DA, Resende M, Sampaio LC.

Int J Cardiol. 2018 Apr 15;257:272-273. doi: 10.1016/j.ijcard.2017.12.110. No abstract available.

PMID:
29506705
2.

Premature atherosclerosis in premenopausal women: Does cytokine balance play a role?

Eastwood JA, Taylor DA, Johnson BD, Resende M, Sharaf BL, Ahmed B, Minissian M, Shufelt C, Merz NB.

Med Hypotheses. 2017 Nov;109:38-41. doi: 10.1016/j.mehy.2017.09.010. Epub 2017 Sep 21.

PMID:
29150290
3.

Peripheral Blood Cytokine Levels After Acute Myocardial Infarction: IL-1β- and IL-6-Related Impairment of Bone Marrow Function.

Shahrivari M, Wise E, Resende M, Shuster JJ, Zhang J, Bolli R, Cooke JP, Hare JM, Henry TD, Khan A, Taylor DA, Traverse JH, Yang PC, Pepine CJ, Cogle CR; Cardiovascular Cell Therapy Research Network (CCTRN).

Circ Res. 2017 Jun 9;120(12):1947-1957. doi: 10.1161/CIRCRESAHA.116.309947. Epub 2017 May 10.

4.

Evaluation of Cell Therapy on Exercise Performance and Limb Perfusion in Peripheral Artery Disease: The CCTRN PACE Trial (Patients With Intermittent Claudication Injected With ALDH Bright Cells).

Perin EC, Murphy MP, March KL, Bolli R, Loughran J, Yang PC, Leeper NJ, Dalman RL, Alexander J, Henry TD, Traverse JH, Pepine CJ, Anderson RD, Berceli S, Willerson JT, Muthupillai R, Gahremanpour A, Raveendran G, Velasquez O, Hare JM, Hernandez Schulman I, Kasi VS, Hiatt WR, Ambale-Venkatesh B, Lima JA, Taylor DA, Resende M, Gee AP, Durett AG, Bloom J, Richman S, G'Sell P, Williams S, Khan F, Gyang Ross E, Santoso MR, Goldman J, Leach D, Handberg E, Cheong B, Piece N, DiFede D, Bruhn-Ding B, Caldwell E, Bettencourt J, Lai D, Piller L, Simpson L, Cohen M, Sayre SL, Vojvodic RW, Moyé L, Ebert RF, Simari RD, Hirsch AT; Cardiovascular Cell Therapy Research Network (CCTRN).

Circulation. 2017 Apr 11;135(15):1417-1428. doi: 10.1161/CIRCULATIONAHA.116.025707. Epub 2017 Feb 16.

5.

Identification of cardiovascular risk factors associated with bone marrow cell subsets in patients with STEMI: a biorepository evaluation from the CCTRN TIME and LateTIME clinical trials.

Contreras A, Orozco AF, Resende M, Schutt RC, Traverse JH, Henry TD, Lai D, Cooke JP, Bolli R, Cohen ML, Moyé L, Pepine CJ, Yang PC, Perin EC, Willerson JT, Taylor DA; Cardiovascular Cell Therapy Research Network (CCTRN).

Basic Res Cardiol. 2017 Jan;112(1):3. Epub 2016 Nov 23.

6.

Bone marrow cell characteristics associated with patient profile and cardiac performance outcomes in the LateTIME-Cardiovascular Cell Therapy Research Network (CCTRN) trial.

Bhatnagar A, Bolli R, Johnstone BH, Traverse JH, Henry TD, Pepine CJ, Willerson JT, Perin EC, Ellis SG, Zhao DX, Yang PC, Cooke JP, Schutt RC, Trachtenberg BH, Orozco A, Resende M, Ebert RF, Sayre SL, Simari RD, Moyé L, Cogle CR, Taylor DA; Cardiovascular Cell Therapy Research Network (CCTRN).

Am Heart J. 2016 Sep;179:142-50. doi: 10.1016/j.ahj.2016.06.018. Epub 2016 Jul 6.

7.

Identification of Bone Marrow Cell Subpopulations Associated With Improved Functional Outcomes in Patients With Chronic Left Ventricular Dysfunction: An Embedded Cohort Evaluation of the FOCUS-CCTRN Trial.

Taylor DA, Perin EC, Willerson JT, Zierold C, Resende M, Carlson M, Nestor B, Wise E, Orozco A, Pepine CJ, Henry TD, Ellis SG, Zhao DX, Traverse JH, Cooke JP, Schutt RC, Bhatnagar A, Grant MB, Lai D, Johnstone BH, Sayre SL, Moyé L, Ebert RF, Bolli R, Simari RD, Cogle CR; Cardiovascular Cell Therapy Research Network (CCTRN).

Cell Transplant. 2016;25(9):1675-1687. Epub 2015 Nov 19.

8.

Bone marrow characteristics associated with changes in infarct size after STEMI: a biorepository evaluation from the CCTRN TIME trial.

Schutt RC, Trachtenberg BH, Cooke JP, Traverse JH, Henry TD, Pepine CJ, Willerson JT, Perin EC, Ellis SG, Zhao DX, Bhatnagar A, Johnstone BH, Lai D, Resende M, Ebert RF, Wu JC, Sayre SL, Orozco A, Zierold C, Simari RD, Moyé L, Cogle CR, Taylor DA; Cardiovascular Cell Therapy Research Network (CCTRN).

Circ Res. 2015 Jan 2;116(1):99-107. doi: 10.1161/CIRCRESAHA.116.304710. Epub 2014 Nov 18.

9.

Building solutions for cardiovascular disease in women.

Resende MM, Taylor DA.

Tex Heart Inst J. 2013;40(3):285-7. No abstract available.

10.

Characterization of the genomic structure and function of regions influencing renin and angiogenesis in the SS rat.

Stodola TJ, de Resende MM, Sarkis AB, Didier DN, Jacob HJ, Huebner N, Hummel O, Saar K, Moreno C, Greene AS.

Physiol Genomics. 2011 Jul 14;43(13):808-17. doi: 10.1152/physiolgenomics.00171.2010. Epub 2011 Apr 26.

11.

Role of the renin angiotensin system on bone marrow-derived stem cell function and its impact on skeletal muscle angiogenesis.

de Resende MM, Stodola TJ, Greene AS.

Physiol Genomics. 2010 Aug;42(3):437-44. doi: 10.1152/physiolgenomics.00037.2010. Epub 2010 May 25.

12.

Effect of ANG II on endothelial cell apoptosis and survival and its impact on skeletal muscle angiogenesis after electrical stimulation.

de Resende MM, Greene AS.

Am J Physiol Heart Circ Physiol. 2008 Jun;294(6):H2814-21. doi: 10.1152/ajpheart.00095.2008. Epub 2008 Apr 25.

13.

Congenic strains reveal the effect of the renin gene on skeletal muscle angiogenesis induced by electrical stimulation.

de Resende MM, Amaral SL, Moreno C, Greene AS.

Physiol Genomics. 2008 Mar 14;33(1):33-40. doi: 10.1152/physiolgenomics.00150.2007. Epub 2008 Jan 15.

PMID:
18198281
14.
15.

Combined effects of low-dose spironolactone and captopril therapy in a rat model of genetic hypertrophic cardiomyopathy.

de Resende MM, Kriegel AJ, Greene AS.

J Cardiovasc Pharmacol. 2006 Dec;48(6):265-73.

PMID:
17204904
16.

Role of endothelial cell apoptosis in regulation of skeletal muscle angiogenesis during high and low salt intake.

de Resende MM, Amaral SL, Munzenmaier DH, Greene AS.

Physiol Genomics. 2006 Apr 13;25(2):325-35. Epub 2006 Feb 7.

PMID:
16464974
17.

Regulation of cardiac and renal mineralocorticoid receptor expression by captopril following myocardial infarction in rats.

de Resende MM, Kauser K, Mill JG.

Life Sci. 2006 May 22;78(26):3066-73. Epub 2006 Jan 18.

PMID:
16413583
18.

Spironolactone prevents cardiac collagen proliferation after myocardial infarction in rats.

Mill JG, Milanez Mda C, de Resende MM, Gomes Mda G, Leite CM.

Clin Exp Pharmacol Physiol. 2003 Oct;30(10):739-44.

PMID:
14516412
19.

Alternate angiotensin II-forming pathways and their importance in physiological or physiopathological conditions.

Resende MM, Mill JG.

Arq Bras Cardiol. 2002 Apr;78(4):425-38. Review. English, Portuguese. No abstract available.

20.

Calpain activity of hypertrophic hearts from hypertensive rats.

Cicilini MA, Resende MM, Bissoli NS, Vasquez EC, Cabral AM.

Braz J Med Biol Res. 1995 Jun;28(6):621-5.

PMID:
8547842

Supplemental Content

Loading ...
Support Center